Compare RDY & AR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RDY | AR |
|---|---|---|
| Founded | 1984 | 2002 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 10.7B |
| IPO Year | 2001 | 2013 |
| Metric | RDY | AR |
|---|---|---|
| Price | $13.71 | $38.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | $16.90 | ★ $47.13 |
| AVG Volume (30 Days) | 2.5M | ★ 5.0M |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.52% | N/A |
| EPS Growth | N/A | ★ 1027.78 |
| EPS | N/A | ★ 1.72 |
| Revenue | N/A | ★ $5,275,823,000.00 |
| Revenue This Year | $7.72 | $29.74 |
| Revenue Next Year | $3.50 | $5.07 |
| P/E Ratio | ★ $18.67 | $22.94 |
| Revenue Growth | N/A | ★ 21.97 |
| 52 Week Low | $12.77 | $29.10 |
| 52 Week High | $16.17 | $45.75 |
| Indicator | RDY | AR |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 50.92 |
| Support Level | $12.90 | $32.86 |
| Resistance Level | $13.96 | $45.75 |
| Average True Range (ATR) | 0.26 | 1.19 |
| MACD | 0.10 | 0.18 |
| Stochastic Oscillator | 65.38 | 74.63 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Antero Resources, based in Denver, explores for and produces natural gas and natural gas liquids in the United States and Canada. At the end of 2025, the company reported proven reserves of 19.1 trillion cubic feet of natural gas equivalent. Production averaged approximately 3,442 million cubic feet of equivalent per day in 2025 at a ratio of 35% liquids and 65% natural gas.